Bottom line
How much do XBI and LFSC overlap?
16% of their top holdings overlap by weight. 5 securities appear in both funds' top 25, making up 5.8% of XBI's assets and 26.4% of LFSC's. They are substantially different portfolios, so owning both adds real diversification.
XBI holds far more positions (161 vs 40), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings XBI and LFSC have in common
| Holding | % of XBI | % of LFSC | Overlap |
|---|---|---|---|
| Dianthus Therapeutics Inc | 1.18% | 3.09% | 1.18% |
| Cytokinetics Inc | 1.18% | 3.16% | 1.18% |
| Mirum Pharmaceuticals Inc | 1.16% | 4.92% | 1.16% |
| Cogent Biosciences Inc | 1.14% | 7.53% | 1.14% |
| Travere Therapeutics Inc | 1.13% | 7.67% | 1.13% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in XBI
- State Street Global Advisors — 5.87%
- Apogee Therapeutics Inc — 1.49%
- Moderna Inc — 1.41%
- Twist Bioscience Corp — 1.41%
- Oruka Therapeutics Inc — 1.38%
- Kymera Therapeutics Inc — 1.36%
- Viking Therapeutics Inc — 1.30%
- Praxis Precision Medicines Inc — 1.29%
- Erasca Inc — 1.27%
- Revolution Medicines Inc — 1.20%
- Rhythm Pharmaceuticals Inc — 1.20%
- CG oncology Inc — 1.20%
- SELLAS Life Sciences Group Inc — 1.19%
- Vaxcyte Inc — 1.19%
- Natera Inc — 1.16%
Only in LFSC
- LivaNova PLC — 7.11%
- Spyre Therapeutics Inc — 6.41%
- Guardant Health Inc — 5.52%
- Corcept Therapeutics Inc — 4.79%
- United Therapeutics Corp — 4.16%
- VeraDermics Inc — 3.42%
- Savara Inc — 3.22%
- Nektar Therapeutics — 3.14%
- Trevi Therapeutics Inc — 3.12%
- Axsome Therapeutics Inc — 2.84%
- Billiontoone Inc — 2.73%
- TransMedics Group Inc — 2.68%
- Viridian Therapeutics Inc — 2.24%
- ICU Medical Inc — 2.09%
- Corvus Pharmaceuticals Inc — 1.95%
Asset mix
| Asset type | XBI | LFSC |
|---|---|---|
| Stocks | 99.9% | 100.0% |
| Cash & short-term funds | 5.9% | — |
| Equity derivatives | 0.1% | — |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)
Country mix
| Country | XBI | LFSC |
|---|---|---|
| US | 100.8% | 92.0% |
| GB | — | 7.1% |
| IE | 1.2% | — |
| BM | 1.2% | — |
| NL | 1.0% | — |
| CH | 1.0% | — |
| SG | — | 1.0% |
| VG | 0.5% | — |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)
Check another pair
FAQ
How much do XBI and LFSC overlap?
What stocks do XBI and LFSC have in common?
Should I own both XBI and LFSC?
Which holds more stocks, XBI or LFSC?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.